Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 Jan;25(1):13-18.
doi: 10.1016/s0145-2126(00)00073-4.

Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment

R Hast  1 , J Wallvik, A Folin, P Bernell, L Stenke
Affiliations
Clinical Trial

Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment

R Hast et al. Leuk Res. 2001 Jan.

Abstract

The outcome of continued EPO therapy was studied in 18 responding MDS patients. The EPO dose was reduced in a stepwise fashion to find the lowest possible maintenance dose. Relapses of anemia were associated with either progressive disease or reduction of the administered EPO dose. In the latter group second responses to renewed EPO therapy were readily achieved. Long-term responses were seen in about a third of the patients. Thus, it seems safe to reduce the EPO dose among responding patients. This approach may have advantages both from a medical and a socio-economic perspective.

PubMed Disclaimer

Comment in

Publication types